Literature DB >> 28973621

Trends and Patterns of Differences in Chronic Respiratory Disease Mortality Among US Counties, 1980-2014.

Laura Dwyer-Lindgren1, Amelia Bertozzi-Villa1, Rebecca W Stubbs1, Chloe Morozoff1, Shreya Shirude1, Mohsen Naghavi1, Ali H Mokdad1, Christopher J L Murray1.   

Abstract

Importance: Chronic respiratory diseases are an important cause of death and disability in the United States. Objective: To estimate age-standardized mortality rates by county from chronic respiratory diseases. Design, Setting, and Participants: Validated small area estimation models were applied to deidentified death records from the National Center for Health Statistics and population counts from the US Census Bureau, National Center for Health Statistics, and Human Mortality Database to estimate county-level mortality rates from 1980 to 2014 for chronic respiratory diseases. Exposure: County of residence. Main Outcomes and Measures: Age-standardized mortality rates by county, year, sex, and cause.
Results: A total of 4 616 711 deaths due to chronic respiratory diseases were recorded in the United States from January 1, 1980, through December 31, 2014. Nationally, the mortality rate from chronic respiratory diseases increased from 40.8 (95% uncertainty interval [UI], 39.8-41.8) deaths per 100 000 population in 1980 to a peak of 55.4 (95% UI, 54.1-56.5) deaths per 100 000 population in 2002 and then declined to 52.9 (95% UI, 51.6-54.4) deaths per 100 000 population in 2014. This overall 29.7% (95% UI, 25.5%-33.8%) increase in chronic respiratory disease mortality from 1980 to 2014 reflected increases in the mortality rate from chronic obstructive pulmonary disease (by 30.8% [95% UI, 25.2%-39.0%], from 34.5 [95% UI, 33.0-35.5] to 45.1 [95% UI, 43.7-46.9] deaths per 100 000 population), interstitial lung disease and pulmonary sarcoidosis (by 100.5% [95% UI, 5.8%-155.2%], from 2.7 [95% UI, 2.3-4.2] to 5.5 [95% UI, 3.5-6.1] deaths per 100 000 population), and all other chronic respiratory diseases (by 42.3% [95% UI, 32.4%-63.8%], from 0.51 [95% UI, 0.48-0.54] to 0.73 [95% UI, 0.69-0.78] deaths per 100 000 population). There were substantial differences in mortality rates and changes in mortality rates over time among counties, and geographic patterns differed by cause. Counties with the highest mortality rates were found primarily in central Appalachia for chronic obstructive pulmonary disease and pneumoconiosis; widely dispersed throughout the Southwest, northern Great Plains, New England, and South Atlantic for interstitial lung disease; along the southern half of the Mississippi River and in Georgia and South Carolina for asthma; and in southern states from Mississippi to South Carolina for other chronic respiratory diseases. Conclusions and Relevance: Despite recent declines in mortality from chronic respiratory diseases, mortality rates in 2014 remained significantly higher than in 1980. Between 1980 and 2014, there were important differences in mortality rates and changes in mortality by county, sex, and particular chronic respiratory disease type. These estimates may be helpful for informing efforts to improve prevention, diagnosis, and treatment.

Entities:  

Mesh:

Year:  2017        PMID: 28973621      PMCID: PMC5818814          DOI: 10.1001/jama.2017.11747

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

1.  Pneumoconiosis and advanced occupational lung disease among surface coal miners--16 states, 2010-2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-15       Impact factor: 17.586

2.  Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.

Authors:  Amir Qaseem; Timothy J Wilt; Steven E Weinberger; Nicola A Hanania; Gerard Criner; Thys van der Molen; Darcy D Marciniuk; Tom Denberg; Holger Schünemann; Wisia Wedzicha; Roderick MacDonald; Paul Shekelle
Journal:  Ann Intern Med       Date:  2011-08-02       Impact factor: 25.391

3.  Multilevel regression and poststratification for small-area estimation of population health outcomes: a case study of chronic obstructive pulmonary disease prevalence using the behavioral risk factor surveillance system.

Authors:  Xingyou Zhang; James B Holt; Hua Lu; Anne G Wheaton; Earl S Ford; Kurt J Greenlund; Janet B Croft
Journal:  Am J Epidemiol       Date:  2014-03-04       Impact factor: 4.897

4.  Algorithms for enhancing public health utility of national causes-of-death data.

Authors:  Mohsen Naghavi; Susanna Makela; Kyle Foreman; Janaki O'Brien; Farshad Pourmalek; Rafael Lozano
Journal:  Popul Health Metr       Date:  2010-05-10

5.  National trends in silicosis mortality in the United States, 1981-2004.

Authors:  Ki Moon Bang; Michael D Attfield; John M Wood; Girija Syamlal
Journal:  Am J Ind Med       Date:  2008-09       Impact factor: 2.214

6.  Asbestosis mortality in the USA: facts and predictions.

Authors:  V C dos Santos Antao; G A Pinheiro; J T Wassell
Journal:  Occup Environ Med       Date:  2008-11-18       Impact factor: 4.402

7.  Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010.

Authors:  Earl S Ford; David M Mannino; Anne G Wheaton; Letitia Presley-Cantrell; Yong Liu; Wayne H Giles; Janet B Croft
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 8.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20

9.  COPD surveillance--United States, 1999-2011.

Authors:  Earl S Ford; Janet B Croft; David M Mannino; Anne G Wheaton; Xingyou Zhang; Wayne H Giles
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

10.  Cigarette smoking prevalence in US counties: 1996-2012.

Authors:  Laura Dwyer-Lindgren; Ali H Mokdad; Tanja Srebotnjak; Abraham D Flaxman; Gillian M Hansen; Christopher Jl Murray
Journal:  Popul Health Metr       Date:  2014-03-24
View more
  30 in total

1.  Exacerbation-Prone Asthma.

Authors:  Loren C Denlinger; Peter Heymann; Rene Lutter; James E Gern
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-22

2.  Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Catherine Bonham; Cara Hrusch; Paul Nolan; Wesley Klejch; Shashi Bellam; Uday Mehta; Kiran Thakrar; Janelle Vu Pugashetti; Aliya N Husain; Steven M Montner; Christopher M Straus; Rekha Vij; Anne I Sperling; Imre Noth; Mary E Strek; Jonathan H Chung
Journal:  Am J Respir Crit Care Med       Date:  2019-03-15       Impact factor: 21.405

Review 3.  Molecular profiling in sarcoidosis.

Authors:  Nicholas K Arger; Brian O'Connor; Laura L Koth
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

4.  Rice Consumption and Subclinical Lung Disease in US Adults: Observational Evidence From the Multi-Ethnic Study of Atherosclerosis.

Authors:  Tiffany R Sanchez; Elizabeth C Oelsner; David J Lederer; Christian M Lo Cascio; Miranda R Jones; Maria Grau-Perez; Kevin A Francesconi; Walter Goessler; Matthew S Perzanowski; R Graham Barr; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2019-09-01       Impact factor: 4.897

5.  CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA.

Authors:  Ayodeji Adegunsoye; Julie M Neborak; Daisy Zhu; Benjamin Cantrill; Nicole Garcia; Justin M Oldham; Imre Noth; Rekha Vij; Tomasz J Kuzniar; Shashi K Bellam; Mary E Strek; Babak Mokhlesi
Journal:  Chest       Date:  2020-05-22       Impact factor: 9.410

6.  Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Brett C Bade; Eric C DeRycke; Christine Ramsey; Melissa Skanderson; Kristina Crothers; Sally Haskell; Bevanne Bean-Mayberry; Cynthia Brandt; Lori A Bastian; Kathleen M Akgün
Journal:  Ann Am Thorac Soc       Date:  2019-06

7.  The Association of Airflow Obstruction with Occupational Exposures in a Sample of Rural Adults in Iowa.

Authors:  P K Henneberger; M J Humann; X Liang; B C Doney; K M Kelly; J M Cox-Ganser
Journal:  COPD       Date:  2020-06-25       Impact factor: 2.409

8.  Estimating the long-run relationship between state cigarette taxes and county life expectancy.

Authors:  Aaron Baum; Sandra Aguilar-Gomez; James Lightwood; Emilie Bruzelius; Stanton A Glantz; Sanjay Basu
Journal:  Tob Control       Date:  2019-01-31       Impact factor: 7.552

9.  Place of Death for Individuals With Chronic Lung Disease: Trends and Associated Factors From 2003 to 2017 in the United States.

Authors:  Sarah H Cross; E Wesley Ely; Dio Kavalieratos; James A Tulsky; Haider J Warraich
Journal:  Chest       Date:  2020-03-27       Impact factor: 9.410

10.  CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.

Authors:  Nicholas K Arger; Melissa E Ho; Isabel E Allen; Bryan S Benn; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-11-20       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.